Spots Global Cancer Trial Database for Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi

Official Title: Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi

Study ID: NCT03094273

Conditions

Dysplastic Nevi

Interventions

Saucerization biopsy

Study Description

Brief Summary: Non-interventional study to evaluate the utility of removing Dysplastic Nevi with a defined 2 mm margin.

Detailed Description: This is a prospective, observational study to evaluate the utility of removing Dysplastic Nevi (DN) with a defined 2 mm margin. This is a non-interventional study that will observe the pathology results following a standard of care biopsy. Principal Investigator (PI) hypothesize that the majority of lesions removed with this technique will have margins free of nevus cells on examination of histopathological sections. Hence, pathologists will not suggest that an additional excision be performed to remove any residual nevus. PI also hypothesize that if biopsy sites are followed over time, the rate of nevus recurrence will be low, because investigators would have removed the majority, if not all of the lesion at the time of initial biopsy.